GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 14 analysts with an average price target of $82.74. This is a potential upside of $11.99 (16.95%) from yesterday's end of day stock price of $70.75.

Globus Medical's activity chart (see below) currently has 210 price targets and 212 ratings on display. The stock rating distribution of GMED is 43.28% HOLD, 53.73% BUY and 2.99% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.87% with an average time for these price targets to be met of 294.15 days.

Highest price target for GMED is $115, Lowest price target is $82, average price target is $97.33.

Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 18-Mar-2025. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 29 are a HOLD (43.28%), 36 are a BUY (53.73%), 2 are a SELL (2.99%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$82

$13.17 (19.13%)

$90

21 days ago
(18-Mar-2025)

24/26 (92.31%)

$10.41 (14.54%)

347

Hold

21 days ago
(18-Mar-2025)

3/3 (100%)

$10.44 (17.24%)

499

Buy

$103

$34.17 (49.64%)

$93

1 months 15 days ago
(24-Feb-2025)

21/22 (95.45%)

$22.98 (28.72%)

359

Hold

1 months 15 days ago
(24-Feb-2025)

1/1 (100%)

$4.73 (18.01%)

469

Buy

$94

$25.17 (36.57%)

$92

1 months 18 days ago
(21-Feb-2025)

8/9 (88.89%)

$13.72 (17.09%)

122

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 294.15 days on average for the stock forecasts to be realized with a an average price target met ratio 92.87

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

JASON WITTES

Which analyst has the most public recommendations on GMED (Globus Medical)?

Jason Wittes has 9 price targets and 8 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Jason Wittes with highest potential upside - $46.17

Which analyst is the currently most reserved on GMED (Globus Medical)?

Steven Lichtman with lowest potential downside - -$45.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?